Skip to content
Dr. Grey AI

Supplement

Bitter Melon

Bitter melon is a gourd whose fruit and extracts contain plant compounds that may influence how the body handles sugar. People mostly look at it for blood sugar in diabetes, but pooled trials found no significant change in fasting glucose or HbA1c, and the evidence is limited. One small 12-week prediabetes trial found better after-meal glucose, while low blood sugar has been reported, including in children.

Best evidence
Grade B
Conditions studied
2
Outcomes
6
Graded outcomes
0231

Evidence by condition

  • Strong
  • Moderate
  • Limited
  • Very limited

2 conditions

Diabetes

Diabetes: outcomes studied for Bitter Melon
GradeOutcomeEffectSizeStudiesPeopleStudies list
Safety and Tolerability

RCTs show good tolerability - adverse events similar to placebo. Common AEs: GI symptoms (nausea, diarrhea, abdominal discomfort), headache. No significant liver enzyme changes in 12-week trials. ALT/AST stable or slightly declined.

Improves (the measure goes up)Moderate effect
Hypoglycemia Risk

SAFETY CONCERN: Hypoglycemic coma and convulsions reported in children. Risk increases when combined with diabetes medications. Case reports of serious hypoglycemia. Caution required with concurrent antidiabetic therapy.

Worsens (the measure goes up)Moderate effect
Fasting Blood Glucose

Meta-analysis of RCTs: No significant effect on fasting blood glucose vs placebo (MD -0.03, 95% CI -0.38 to 0.31). High heterogeneity among studies. Individual trials show mixed results with some showing reductions and others showing no effect.

NoneNo effect
HbA1c Reduction

Meta-analysis: No significant effect on HbA1c (MD -0.12, 95% CI -0.35 to 0.11, I²=56%). Short study durations and small sample sizes may explain inconsistent results. Some individual studies report modest HbA1c reductions.

NoneNo effect
Postprandial Glucose

Korean prediabetes RCT (12 weeks): Improved postprandial glucose levels, possibly via glucagon suppression. More consistent effect than fasting glucose. Long-term cohort studies needed to confirm prophylactic benefits.

Improves (the measure goes down)Small effect

Metabolic Syndrome

Metabolic Syndrome: outcomes studied for Bitter Melon
GradeOutcomeEffectSizeStudiesPeopleStudies list
Traditional Use for Metabolic Syndrome

Systematic review: Insufficient high-quality evidence to support efficacy for metabolic syndrome parameters. Traditional use widespread but clinical validation lacking. More rigorous trials needed.

Small effect

Key findings

  • Safety and TolerabilityDiabetesImproves (the measure goes up)
  • Hypoglycemia RiskDiabetesWorsens (the measure goes up)
  • Fasting Blood GlucoseDiabetes

Safety notes in the studies

  • RCTs show good tolerability - adverse events similar to placebo.
  • Risk increases when combined with diabetes medications.
  • Caution required with concurrent antidiabetic therapy.

Shop the evidence-backed picks

Third-party tested Bitter Melon products, in the forms the graded studies used where we can match them.

  • Grade B

Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure

Studies cited

8 studies from PubMed

  1. Momordica charantia (bitter melon) efficacy and safety on glucose metabolism in Korean prediabetes participants: a 12-week, randomized clinical studyFood Sci Biotechnol, 2023 · PMID 36882665
  2. The metabolic effect of Momordica charantia cannot be determined based on the available clinical evidence: a systematic review and meta-analysis of randomized clinical trialsFront Nutr, 2023 · PMID 38179591
  3. Momordica charantia L.-Diabetes-Related Bioactivities, Quality Control, and Safety ConsiderationsFront Pharmacol, 2022 · PMID 35656300
  4. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitusComplement Ther Med, 2020 · PMID 32951763
  5. The effect of bitter melon (Mormordica charantia) in patients with diabetes mellitus: a systematic review and meta-analysisJ Ethnopharmacol, 2019 · PMID 25504465
  6. Momordica charantia, a Nutraceutical Approach for Inflammatory Related DiseasesFront Pharmacol, 2019 · PMID 31139079
  7. Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetesInt J Environ Res Public Health, 2014 · PMID 24695081
  8. Bitter melon (Momordica charantia): a review of efficacy and safetyAm J Health Syst Pharm, 2003 · PMID 12625217